OHC Representatives Visit with Washington D.C. Leadership to Fight for Patient Cancer Rights
OHC representatives Dr. Randy Broun and Brian Bourbeau are meeting with the offices of Senators Sherrod Brown, Rob Portman, and Rand Paul to express opposition to a recent Medicare proposal that would remove $150 million in funding for anti-cancer therapies. Titled the Part B Drug Payment Model, the proposal will change Medicare drug payments for nearly three-fourths of the nation, impacting community oncology practices already struggling under the impact of sequestration.
OHC, a national leader in oncology care and payment reform, is working with local health insurers, accreditation organizations, and other community practices to improve quality, access, and overall health care. OHC’s goal is to achieve the highest health outcome for all cancer patients.
Unfortunately, this Medicare proposal threatens this goal. Instead, Medicare beneficiaries risk losing access to many of the most effective cancer treatments that are available for their specific condition. Health care providers and consumers must not stand idle while others determine their treatment options.
We are requesting our representatives stand with us in demanding the Centers for Medicare & Medicaid Services to withdraw their proposal, and to protect the right of choice for high-quality cancer care for all patients.
To learn more and become involved, visit www.cancerexperiment.com. Please call, email, or tweet your representative. Together we can make a difference and protect your rights for cancer treatment. Make your voice heard.